No-Fee CE: Myopia Beyond 2025

This course is designed to help readers understand the development of the disease of myopia. The article identifies areas in which clinicians can intervene to slow progression using the latest research evidence from the past year.

By
CARA FRASCO LAI, OD, MS
Nicky Lai, OD, MS
March 1, 2026
29 min

Contact Lens Spectrum

Overview

This report highlights the latest advancements in myopia management, emphasizing the importance of early intervention and evidence-based strategies to slow myopia progression. Key findings include the impact of parental myopia and lifestyle factors on disease onset, as well as the significance of FDA-approved treatments.

Background

Myopia is a growing global concern, particularly among children, with significant implications for visual health. Understanding the mechanisms of myopia progression and effective management strategies is crucial for eyecare professionals. Recent FDA approvals and emerging research provide new tools and insights for clinicians to address this condition proactively.

Data Highlights

No numerical data provided in the source material.

Key Findings

Parental myopia and reduced outdoor time are significant risk factors for myopia development.
Low hyperopic reserve is the strongest predictive factor for myopic progression.
A 1-year delay in myopia onset can reduce final myopia levels by 0.75 D in East Asian children.
FDA approval of spectacle lenses for myopia control enhances treatment options for practitioners.
Emerging research indicates that changes in choroidal thickness may predict treatment efficacy.

Clinical Implications

Clinicians should incorporate lifestyle recommendations alongside optical and pharmaceutical treatments to optimize myopia management. Understanding risk factors and early intervention can significantly impact the long-term outcomes for children at risk of developing myopia.

Conclusion

The evolving landscape of myopia management necessitates that eyecare professionals stay informed about the latest research and treatment options. Proactive, evidence-based approaches are essential for effectively addressing myopia progression.